Cargando…
Drug-induced psoriasis: clinical perspectives
Exposure to certain drugs can elicit an induction or exacerbation of psoriasis. Although well-conducted systematic studies on drug-related psoriasis are mostly lacking, traditionally strong associations have been documented for beta-blockers, lithium, antimalarial drugs such as (hydroxy)chloroquine,...
Autores principales: | Balak, Deepak MW, Hajdarbegovic, Enes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774610/ https://www.ncbi.nlm.nih.gov/pubmed/29387611 http://dx.doi.org/10.2147/PTT.S126727 |
Ejemplares similares
-
Fumaric acid esters in the management of psoriasis
por: Balak, Deepak MW
Publicado: (2015) -
The Association between Atopic Disorders and Keloids: A Case-control Study
por: Hajdarbegovic, Enes, et al.
Publicado: (2015) -
Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study
por: Balak, Deepak MW, et al.
Publicado: (2013) -
Anti‐interleukin‐17A for pityriasis rubra pilaris: catching the psoriasis biologic wave
por: Balak, Deepak M.W., et al.
Publicado: (2022) -
Atopy in cutaneous and arthropatic psoriasis
por: Hajdarbegovic, E, et al.
Publicado: (2010)